Virtus LifeSci Biotech Clinical Trials ETF Rating → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free BBC Stock Alerts $25.60 +0.90 (+3.64%) (As of 04/26/2024 ET) Add Compare Share Share RatingsStock AnalysisChartHoldingsRatingsStock AnalysisChartHoldingsRatings Virtus LifeSci Biotech Clinical Trials ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBC Aggregate RatingModerate Buy2.85Holdings in BBC have an aggregate rating of Moderate Buy based on 338 analyst ratings issued in the past year covering 49 companies (63.3% of the portfolio).BBC Aggregate Price Target$43.7971.07% UpsideHigh Prediction$63.05Average Prediction$43.79Low Prediction$27.58Holdings in BBC have an aggregate price target of $43.79 and a range of $27.58 to $63.05 covering 49 companies (63.3% of the portfolio).BBC Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy28 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Virtus LifeSci Biotech Clinical Trials ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 49 BBC Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.85%VKTXViking Therapeutics$74.31+7.9%5 of 5 stars3.00$112.25 51.1%10Earnings ReportAnalyst ReportAnalyst Revision2.79%ALPNAlpine Immune Sciences$64.56-0.1%2 of 5 stars2.27$50.33 -22.0%11Short Interest ↓2.59%VERAVera Therapeutics$39.65+2.5%1 of 5 stars3.00$32.29 -18.6%82.44%RNAAvidity Biosciences$24.36+2.2%1 of 5 stars3.00$36.33 49.2%62.05%SYRESpyre Therapeutics$33.56+3.4%1 of 5 stars3.00$39.20 16.8%71.87%APGEApogee Therapeutics$47.13+2.8%1 of 5 stars3.00$71.83 52.4%71.76%DYNDyne Therapeutics$24.73+4.4%4 of 5 stars3.14$37.43 51.3%7Short Interest ↑News Coverage1.75%SANASana Biotechnology$8.72+2.6%2 of 5 stars2.75$11.67 33.8%4News Coverage1.59%CGEMCullinan Oncology$25.30+31.4%2 of 5 stars3.00$28.75 13.6%6Short Interest ↑High Trading Volume1.54%LQDALiquidia$12.53+1.3%2 of 5 stars2.60$21.00 67.6%5Upcoming Earnings1.52%CYTKCytokinetics$65.34+0.8%4 of 5 stars2.87$79.33 21.4%15Insider SellingShort Interest ↑News Coverage1.49%MGNXMacroGenics$14.56+1.3%4 of 5 stars2.89$18.00 23.6%9Analyst ReportShort Interest ↑News CoverageGap Up1.42%NRIXNurix Therapeutics$12.361 of 5 stars2.83$21.33 72.6%61.40%KROSKeros Therapeutics$57.86+6.8%2 of 5 stars3.00$86.00 48.6%7Upcoming Earnings1.34%MRUSMerus$45.04+0.2%2 of 5 stars3.00$56.33 25.1%11Upcoming EarningsAnalyst RevisionNews Coverage1.30%KURAKura Oncology$19.65+3.4%4 of 5 stars2.88$28.28 43.9%8Upcoming Earnings1.29%FDMT4D Molecular Therapeutics$23.25-1.2%3 of 5 stars3.00$44.22 90.2%101.28%GERNGeron$3.79+6.5%3 of 5 stars3.00$5.33 40.7%3Upcoming EarningsShort Interest ↑News Coverage1.26%IOVAIovance Biotherapeutics$11.64+0.9%5 of 5 stars3.00$24.64 111.7%10Short Interest ↑1.22%MLYSMineralys Therapeutics$11.87+7.5%1 of 5 stars3.00$33.50 182.2%31.19%BCYCBicycle Therapeutics$22.73+0.9%2 of 5 stars2.86$46.86 106.1%7Upcoming EarningsShort Interest ↑1.19%KRYSKrystal Biotech$156.88+0.8%4 of 5 stars3.00$171.00 9.0%91.19%IGMSIGM Biosciences$9.40+22.9%4 of 5 stars2.50$17.44 85.6%81.13%SMMTSummit Therapeutics$3.86+8.7%1 of 5 stars3.00$8.00 107.3%1Upcoming EarningsGap Up1.11%RVMDRevolution Medicines$35.96+1.8%4 of 5 stars3.10$41.20 14.6%10Positive News1.11%KYMRKymera Therapeutics$33.37+0.1%1 of 5 stars2.54$41.20 23.5%13Upcoming EarningsNews Coverage1.07%ALLOAllogene Therapeutics$2.89+1.4%2 of 5 stars2.71$12.94 347.7%7Upcoming Earnings1.07%COGTCogent Biosciences$6.02+0.2%2 of 5 stars2.71$13.67 127.0%7Short Interest ↑1.05%IBRXImmunityBio$7.35+43.8%0 of 5 stars2.00$5.00 -32.0%1Options VolumeNews CoverageHigh Trading Volume1.05%PTGXProtagonist Therapeutics$25.15+2.0%1 of 5 stars3.00$36.00 43.1%4Upcoming Earnings1.03%INBXInhibrx$34.06-0.1%1 of 5 stars2.00$27.00 -20.7%21.02%CRNXCrinetics Pharmaceuticals$42.12-0.4%4 of 5 stars2.91$54.00 28.2%11Upcoming EarningsShort Interest ↑0.99%IDYAIDEAYA Biosciences$39.94+3.4%3 of 5 stars3.00$46.60 16.7%120.97%BHVNBiohaven$38.97+1.1%4 of 5 stars3.00$52.13 33.8%8Analyst ReportInsider BuyingAnalyst RevisionNews Coverage0.97%LYELLyell Immunopharma$2.17-1.4%1 of 5 stars2.50$5.50 153.5%2Upcoming Earnings0.96%ARDXArdelyx$6.42+1.7%4 of 5 stars3.11$12.69 97.6%9Upcoming Earnings0.92%PHATPhathom Pharmaceuticals$9.18+0.9%2 of 5 stars2.75$21.33 132.4%4Analyst Report0.91%ANABAnaptysBio$21.00+11.3%2 of 5 stars2.80$46.22 120.1%100.91%ACLXArcellx$51.92+1.1%3 of 5 stars3.00$75.64 45.7%12Short Interest ↑0.91%PGENPrecigen$1.41+0.7%4 of 5 stars2.33$10.00 609.2%3News Coverage0.89%SNDXSyndax Pharmaceuticals$21.06+2.4%4 of 5 stars2.90$34.42 63.4%10Analyst ReportNews Coverage0.89%ITOSiTeos Therapeutics$10.80+1.9%1 of 5 stars3.00$30.33 180.9%30.89%CLDXCelldex Therapeutics$36.30+0.1%0 of 5 stars2.80$66.00 81.8%5Upcoming Earnings0.88%CMPSCOMPASS Pathways$7.94+1.0%1 of 5 stars3.00$47.40 497.0%5Short Interest ↑0.87%IMTXImmatics$10.01+2.4%0 of 5 stars3.0010.85%ORICORIC Pharmaceuticals$8.07+5.2%3 of 5 stars3.00$19.80 145.4%50.85%SLNOSoleno Therapeutics$37.89+1.5%4 of 5 stars3.00$55.60 46.7%5Positive News0.85%ARCTArcturus Therapeutics$26.55+1.5%2 of 5 stars3.00$61.33 131.0%70.84%PCVXVaxcyte$60.72+1.1%2 of 5 stars3.00$78.50 29.3%4Insider SellingNews Coverage This page (NYSEARCA:BBC) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressWhy Big Pharma is Investing Billions in This BiotechBehind the MarketsJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Clinical Trials ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
